CRISPR Therapeutics AG Uncategorized Contracts & Agreements

10 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Description of Capital Shares
CRISPR Therapeutics AG
Biotechnology
2024
Letter Agreement dated January 6, 2022, by and between CRISPR Therapeutics, Inc. and 105 W First Street Owner, L.L.C
CRISPR Therapeutics AG
Biotechnology
2022
Letter Agreement dated December 16, 2021 by and between CRISPR Therapeutics, Inc. and Pfizer Inc
CRISPR Therapeutics AG
Biotechnology
2022
Description of Capital Shares
CRISPR Therapeutics AG
Biotechnology
2022
Letter Agreement dated April 29, 2021 by and between CRISPR Therapeutics, Inc. and Pfizer Inc
CRISPR Therapeutics AG
Biotechnology
2021
Description of Capital Shares
CRISPR Therapeutics AG
Biotechnology
2021
Option Agreement, dated December 13, 2019, between CRISPR Therapeutics AG and Bayer HealthCare LLC
CRISPR Therapeutics AG
Biotechnology
NY
2020
Description of Capital Shares
CRISPR Therapeutics AG
Biotechnology
2020
Open Market Sale AgreementSM, dated August 30, 2019, by and between CRISPR Therapeutics AG and Jefferies LLC
CRISPR Therapeutics AG
Biotechnology
NY
2019
Open Market Sale AgreementSM, dated August 31, 2018, by and between CRISPR Therapeutics AG and Jefferies LLC
CRISPR Therapeutics AG
Biotechnology
NY
2018